Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 316 - Statistical Leadership for the Future of Healthcare Industry
Type: Topic Contributed
Date/Time: Wednesday, August 5, 2020 : 10:00 AM to 11:50 AM
Sponsor: Biopharmaceutical Section
Abstract #313291
Title: Statistical Leadership for the Future of Healthcare Industry
Author(s): Zoran Antonijevic* and Ouhong Wang* and Richard Vonk* and Qi Jiang* and Liang Fang* and Rui Sammi Tang*
Companies: and Vertex and Bayer Oncology and Seattle Genetics and Myokardia and Servier Pharmaceuticals
Keywords: statistical leadership ; decision making; influencing; collaborative partnership

As scientists in every discipline are generating more data more rapidly than ever before, the need for statistical skills is undisputed. Statistical sciences per se, however, seem to be suffering from low visibility. Resolving this paradox requires strong statistical leadership to multidisciplinary teams. As in the drug development and healthcare field, the teams often combine different areas of quantitative sciences, such as statistics, bioinformatics and data science as well as medical, regulatory and clinical operations. In order to propagate enhanced quantitative decision making in the face of uncertainty, effective influence highlighting the value of statistics to other disciplines is paramount. It also requires great appreciation of the unique capabilities of other functions and disciplines. Collaborative partnerships are crucial for statistics and for statisticians to achieve sizable impact in their organization. This session will feature leaders who started their career in the field of statistics and are very effective collaborators. Some later transitioned to prominent positions beyond their original field of expertise.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2020 program